Galcanezumab leads to conversion from chronic to episodic migraine in real worldJuly 31, 2022Headache & Migraine
Significant preventive effects of eptinezumab in patients with previous unsuccessful migraine treatment July 31, 2022Headache & Migraine
Commentary: Treating Chronic Migraine and Providing Temporary Relief, July 2022July 24, 2022Headache & Migraine
In the Quest for Migraine Relief, The Search for Biomarkers IntensifiesJuly 22, 2022Headache & Migraine
Women with severe migraine with aura have a higher risk for atrial fibrillationJuly 19, 2022Headache & Migraine
Migraine: Atogepant effective and well tolerated as preventive treatmentJuly 19, 2022Headache & Migraine
Migraine significantly correlates with fetal-type posterior cerebral artery in ischemic strokeJuly 19, 2022Headache & Migraine
Ketorolac-metoclopramide combo fails to improve outcomes in children with migraineJuly 19, 2022Headache & Migraine
Lidocaine infusions may effectively treat refractory chronic migraineJuly 19, 2022Headache & Migraine
Fremanezumab efficacy unaffected by migraine type or factors underlying treatment difficultyJuly 19, 2022Headache & Migraine
Real-world data support the use of galcanezumab in difficult-to-treat migraineJuly 19, 2022Headache & Migraine
Chronic migraine: Better headache control with onabotulinumtoxinA dose escalationJuly 19, 2022Headache & Migraine
